"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"

“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”

基本信息

  • 批准号:
    9295591
  • 负责人:
  • 金额:
    $ 20.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2021-12-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT: The goals of this Mentored Clinical Scientist Research Career Development Award (K08) are to A) obtain theoretical and hands-on training in 1) rodent magnetic resonance (MR) and positron emission tomography (PET) molecular imaging and 2) virology and immunology, B) apply this training towards developing a rodent model of viral-induced autoimmune encephalitis, and C) to use the resulting data to create a successful R01 application in the final years of this K08. This award will be a crucial stepping-stone towards my overall goal of developing into an independent autoimmune neurologist that sees patients and studies these diseases in the laboratory, contributing to earlier diagnoses and better treatments for these disabling disorders. Autoimmune encephalitis can be fatal and can lead to significant disability. It is difficult to gather enough patients with autoimmune encephalitis for clinical trials. There is a published rodent model of NMDA receptor (NMDAR) encephalitis. However, it relies on the adoptive transfer of human anti-NMDAR antibodies into the brains of mice. In order to study the pathogenesis of these disorders, it would be particularly important to develop an animal model of NMDAR encephalitis which does not rely on exogenous antibodies. It has been recently recognized in humans that some cases of NMDAR encephalitis are triggered by herpes simplex virus (HSV) encephalitis. Rodent models of HSV encephalitis are established. Preliminary work by our lab showed that some mice with HSV encephalitis make anti-NMDAR antibodies. This research proposal aims to demonstrate the pathogenicity of these antibodies and to use this model to better understand the patho- physiology of NMDAR encephalitis. This will be done by using targeted molecular imaging to understand the mechanisms as well as profiling the immune responses involved in this autoimmune neurologic disorder. I am a board-certified Harvard-trained neurologist with specific clinical fellowship training in autoimmune neurology through the Mayo Clinic. I have obtained the top clinical training available in this field. Furthermore, I have gained additional experience in basic research within this topic by spending time in the laboratory of the renowned autoimmune neurologist Dr. Josep Dalmau, one of my co-mentors on this project. I bring a solid grounding in molecular biology, gained through my Ph.D. studies. In addition, I have a strong publication and funding record. The research career development plan outlined within this proposal will equip me with a better understanding of virology and immunology and the latest methodologies within these fields that can be applied to uncover the pathophysiology of parainfectious autoimmune neurologic disorders. The research environment across the MGH, Harvard, and MIT campuses is outstanding and my mentors have the relevant and necessary expertise to guide this career development plan. I am a full time faculty member in the Massachusetts General Hospital (MGH) Department of Neurology and an Instructor in Neurology at Harvard Medical School. I have the full backing of the chair of my department, Dr. Cudkowicz, to develop into an independent researcher.
项目摘要/摘要:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JENNY J LINNOILA其他文献

JENNY J LINNOILA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JENNY J LINNOILA', 18)}}的其他基金

"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"
“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”
  • 批准号:
    10398467
  • 财政年份:
    2022
  • 资助金额:
    $ 20.18万
  • 项目类别:
"HSV1-Induced NMDA Receptor Encephalitis: a De Novo Murine Model of Autoimmune Encephalitis"
“HSV1 诱导的 NMDA 受体脑炎:自身免疫性脑炎的新生小鼠模型”
  • 批准号:
    10066374
  • 财政年份:
    2017
  • 资助金额:
    $ 20.18万
  • 项目类别:
Signaling Mechanisms Behind nAChR Clustering at the NMJ
NMJ nAChR 聚类背后的信号机制
  • 批准号:
    7482284
  • 财政年份:
    2007
  • 资助金额:
    $ 20.18万
  • 项目类别:
Signaling Mechanisms Behind nAChR Clustering at the NMJ
NMJ nAChR 聚类背后的信号机制
  • 批准号:
    7331196
  • 财政年份:
    2007
  • 资助金额:
    $ 20.18万
  • 项目类别:

相似海外基金

Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Acute Disseminated Encephalomyelitis (ADEM)
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗急性播散性脑脊髓炎 (ADEM)
  • 批准号:
    10755864
  • 财政年份:
    2023
  • 资助金额:
    $ 20.18万
  • 项目类别:
Does early imaging at onset of acute disseminated encephalomyelitis (ADEM) in childhood predict later cognitive impairment?
儿童期急性播散性脑脊髓炎 (ADEM) 发病时的早期影像学检查是否可以预测日后的认知障碍?
  • 批准号:
    182639
  • 财政年份:
    2009
  • 资助金额:
    $ 20.18万
  • 项目类别:
    Studentship Programs
Pathogenesis and pathophysiology of pediatric multiple sclerosis and acute disseminated encephalomyelitis
小儿多发性硬化症和急性播散性脑脊髓炎的发病机制和病理生理学
  • 批准号:
    21591326
  • 财政年份:
    2009
  • 资助金额:
    $ 20.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EARLY ONSET OF MULTIPLE SCLEROSIS AND ACUTE DISSEMINATED ENCEPHALOMYELITIS
多发性硬化症和急性播散性脑脊髓炎的早期发作
  • 批准号:
    7203600
  • 财政年份:
    2004
  • 资助金额:
    $ 20.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了